Aarti Pharma Labs Quarterly Results for Trading Insights
AARTIPHARM • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹28 Cr
QSept 2025
Aarti Pharma Labs Quarterly Results Key Highlights
- Revenue of ₹418 Cr in Sept 2025 (-25.6% vs Mar 2025, -9.7% vs Sept 2024)
- Net Profit of ₹28 Cr in Sept 2025 (-68.2% vs Mar 2025, -49.1% vs Sept 2024)
- EBITDA of ₹74 Cr in Sept 2025 (-48.6% vs Mar 2025)
- Operating Margin of 18.0% in Sept 2025 (-8.0pp vs Mar 2025)
- Earnings Per Share of ₹3.08 in Sept 2025 (-68.4% vs Mar 2025)
Aarti Pharma Labs Quarterly Results Analysis
| Metric | Sept 2025 | Mar 2025 | Jun 2025 | Sept 2024 | Mar 2024 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 418 | 562 | 388 | 463 | 508 | -25.6% | -9.7% |
| Net Profit (₹ Cr) | 28 | 88 | 50 | 55 | 65 | - | - |
| EBITDA (₹ Cr) | 74 | 144 | 95 | 98 | 120 | - | - |
| EPS (₹) | 3.08 | 9.75 | 5.46 | 6.03 | 7.20 | - | - |
| Operating Margin (%) | 18.0% | 26.0% | 24.0% | 20.0% | 23.0% | - | - |
Aarti Pharma Labs Share Price Trend Around Quarterly Results
Visualize Aarti Pharma Labs's 1-year price movement across quarterly results — ideal for logging trades in Aarti Pharma Labs share price
chart using Tickjournal. All values in ₹.
Related Pages for Aarti Pharma Labs
Additional stock information and data for AARTIPHARM
Revenue Trend (₹ Cr)
Sept 2024
463
Jun 2025
388
Mar 2025
562
Sept 2025
418
Net Profit Trend (₹ Cr)
Sept 2024
55
Jun 2025
50
Mar 2025
88
Sept 2025
28
Operating Margin Trend (%)
Sept 2024
20.0%
Jun 2025
24.0%
Mar 2025
26.0%
Sept 2025
18.0%
Sector Competitors - Quarterly Performance Comparison
Comparing Aarti Pharma Labs quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹422,330.94 Cr | 1782.6 | 14,875 | 3,125 | +10.8% | - | 21.0% | 137.1 |
|
Divis Laboratories
Sept 2025 |
₹176,337.50 Cr | 6642.5 | 2,860 | 689 | +7.1% | - | 24.1% | 255.8 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹136,522.12 Cr | 4092.2 | 3,219 | 591 | +11.3% | - | 18.4% | 233.3 |
|
Cipla
Sept 2025 |
₹121,238.47 Cr | 1467.9 | 7,716 | 1,353 | +12.0% | - | 17.5% | 87.7 |
|
Dr Reddys Laborator…
Sept 2025 |
₹104,829.57 Cr | 1242.8 | 9,135 | 1,337 | +1.1% | - | 14.6% | 76.8 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores